Medigus announces new branding and the launch of a new website

0

Tel Aviv, Israel, October 12, 2021 (GLOBE NEWSWIRE) – Medigus Ltd. (Nasdaq: MDGS), a technology company specializing in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, today announced that it has completed a corporate rebranding process, including, but without limited to that, a new brand logo, new website and investor lobby, http://www.medigus.com/.

Medigus’ new branding reflects the business focus and the company’s plans to position itself as an innovative technology company, aligned with its strategic goals to deliver better returns to our shareholders.

On the new website, Medigus partners and investors can find information on all Medigus activities: Charging Robotics Ltd. (100%), Revoltz Ltd. (19.99%), Polyrizon Ltd. (35.86%), ScoutCam Inc. (OTCQB: SCTC) (27.76%), Jeff’s Brands Ltd. (50.03%), Gix Internet Ltd. (TASE: GIX) (33.17%) and Eventer Technologies Ltd. (47.69%).

Medigus recently announced record financial results for the six-month period ended June 30, 2021. Revenues reached an all-time high and totaled $ 2,393,000. Net income for the period reached a record $ 7,927,000. Equity was $ 53,904,000 in cash and cash equivalents amounted to $ 29,642,000 as at June 30, 2021.

About Medigus

Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, primarily in the advanced medical solutions, digital commerce, and electric vehicle markets. Medigus medical solutions affiliations consist of the property of ScoutCam (OTCQB: SCTC) Inc. and Polyzion Ltd. The company’s affiliates in digital commerce include Gix Internet Ltd. (TASE: GIX), Jeff’s Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz are also part of the Company’s portfolio of technology solutions providers. Medigus is listed on the Nasdaq Capital Market. To learn more about Medigus advanced technologies, please visit http://www.medigus.com/

Caution Regarding Forward-Looking Statements

This press release may contain statements which are “forward-looking statements”, which are based on current estimates, assumptions and expectations of Medigus management and its knowledge of the relevant market. The company has tried, to the extent possible, to identify such information and statements by using words such as “anticipate”, “believe”, “consider”, “estimate”, “” “intend to. “,” “Foresee”, “project”, “target”, “potential”, “will”, “would”, “could”, “should”, “continue”, “contemplate” and other similar expressions and their derivations in connection with any discussion of future events, trends or prospects or of future operational or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward-looking statements to describe income aspirations. These forward-looking statements represent Medigus’ expectations or beliefs regarding future events, and it is possible that the results described in this press release will not be achieved. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the future results of Medigus’ business to differ materially from the content and implications of such statements. Other risk factors affecting Medigus are discussed in detail in documents filed by Medigus with the Securities and Exchange Commission. Forward-looking statements are only relevant as of the date on which they are made, and Medigus assumes no obligation to update or revise forward-looking statements, whether as a result of new information, future developments or otherwise. . Neither Medigus nor its shareholders, officers and employees will be responsible for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of securities. by Medigus. Nothing in this press release should be taken as medical or other advice of any kind.

Contact

Tali dinar

Financial director

+ 972-8-6466-880

[email protected]


Source link

Share.

Leave A Reply